Cohero Health, a New York City-based digital health company focused on chronic respiratory disease, has a new CEO: Joe Condurso, former CEO of PatientSafe Solutions.
“We are pleased to welcome Joe to the talented team at Cohero Health,” Cohero cofounder and president Melissa Manice said in a statement. “We all share a deep passion for the use of technology to improve health care and patient quality of life, and I look forward to working with Joe to advance Cohero’s leadership position and strategic direction.”
“Cohero’s suite of interactive, tech-enabled solutions are already having a positive impact on the health of people with respiratory disease by improving patient engagement, treatment compliance and medication adherence,” Condurso said in a statement. “I look forward to working with the board and team of people at Cohero whose intellectual curiosity defines the transformative culture that is leading the way in respiratory disease management.”
Chicago-based online weight loss and diabetes prevention program provider Retrofit has hired three new members to its sales team. Dr. Susan Haluzan will serve as employer sales director in the West, Matt Mrazik will serve as sales director for the East, and Mike Tomback will join as sales director for the West. Haluzan previously worked at Optum, Mrazik has worked at Bayer and Johnson & Johnson, and Tomback comes to Retrofit from Provant Health Solutions.
“We are thrilled to expand our sales team with talented professionals who bring valuable experience and demonstrated success,” Mary Pigatti, CEO of Retrofit, said in a statement. “Building our workforce with proven leaders will further contribute to the tremendous growth and momentum we have experienced as an organization.”
Health engagement platform company Sharecare announced two new hires. Carlos Ferraro Cavallini will join the team as senior vice president of business-to-business technologies and Dave Springer will serve as president of Ornish Lifestyle Medicine, a business unit Sharecare obtained in last year's Healthways acquisition. Cavallini was most recently head of enterprise architecture for Latin America and the Caribbean at Salesforce, while Springer previously ran the US brand at St. Jude Medical.
Both hires are tied to the Healthways acquisition, as Cavallini will also be in charge of Sharecare's Brazilian JV SulAmérica Serviços de Saúde S.A., which also came into the company's portfolio via the Healthways acquisition.
“Sharecare’s passion for leveraging innovation to make populations healthier, happier and more productive isn’t limited to the American healthcare system, and we are excited to embark on expanding into Brazil through our joint venture with our partner, SulAmérica,” Sharecare CEO Jeff Arnold said in a statement. “With Carlos helping to drive that effort, especially given his technological – and cultural – competence, we are forging a clear path to help SulAmérica’s members leverage one comprehensive platform putting all their health in one place, and make a positive impact on the health of Brazil."
Telemedicine company SnapMD has added another member to its clinical advisory board: Dr. Nina Antoniotti, the executive director for telehealth and clinical outreach at the Southern Illinois University School of Medicine. Antoniotti has formerly served as an ATA board member and has been working in the telemedicine field for just shy of 20 years.
“I am honored to serve as a member of the SnapMD Clinical Advisory Board, as I truly believe in the company’s telehealth vision today and what they have planned for the evolution of their platform in the months and years ahead,” Antoniotti said in a statement. “I look forward to working with the executive management and product development teams to further shape the future of the company’s Virtual Care Management offering and their unique approach to telemedicine 3.0.”
John Erickson will join digital diabetes management company GlucoMe as General Manager for North America. Erickson's background is in the pharma world: he was most recently divisional vice president at Abbott Labs and worked at Johnson & Johnson prior to that.
"I am very excited to join GlucoMe, and look forward to helping doctors and patients across the United States better treat diabetes," Erickson said in a statement. "Diabetes management and care are major concerns for tens of millions of American patients, as well as healthcare payers and professionals. GlucoMe's digital technology and strategic roadmap are opening up an exciting avenue to enable simpler and more effective diabetes care resulting in better outcomes. I look forward to working closely with the entire team as GlucoMe takes its next steps forward."jordan shoes for sale outlet leather